Valneva SE (VALN)
NASDAQ: VALN · IEX Real-Time Price · USD
8.88
+0.07 (0.79%)
At close: May 17, 2024, 4:00 PM
8.85
-0.04 (-0.39%)
After-hours: May 17, 2024, 4:00 PM EDT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $605.68 million as of May 17, 2024. Its market cap has decreased by -30.13% in one year.
Market Cap
605.68M
Enterprise Value
643.79M
1-Year Change
-30.13%
Ranking
Category
Stock Price
$8.88
Market Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $605.68M, a decrease of -53.14%. That is a compound annual growth rate of -22.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 616.80M | 0.73% |
May 16, 2024 | 612.30M | -0.39% |
May 15, 2024 | 614.70M | 10.50% |
May 14, 2024 | 556.30M | 5.24% |
May 13, 2024 | 528.60M | 2.56% |
May 10, 2024 | 515.40M | 4.23% |
May 9, 2024 | 494.50M | -1.67% |
May 8, 2024 | 502.90M | -3.46% |
May 7, 2024 | 520.90M | - |
May 6, 2024 | 520.90M | -2.73% |
May 3, 2024 | 535.50M | 3.82% |
May 2, 2024 | 515.80M | -1.90% |
May 1, 2024 | 525.80M | 1.62% |
Apr 30, 2024 | 517.40M | -3.13% |
Apr 29, 2024 | 534.10M | 0.66% |
Apr 26, 2024 | 530.60M | 1.18% |
Apr 25, 2024 | 524.40M | -2.58% |
Apr 24, 2024 | 538.30M | 0.09% |
Apr 23, 2024 | 537.80M | -2.24% |
Apr 22, 2024 | 550.10M | 4.44% |
Apr 19, 2024 | 526.70M | -6.73% |
Apr 18, 2024 | 564.70M | 4.90% |
Apr 17, 2024 | 538.30M | -3.11% |
Apr 16, 2024 | 555.60M | -5.89% |
Apr 15, 2024 | 590.40M | -0.12% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ORIC Pharmaceuticals | 620.62M |
Phathom Pharmaceuticals | 618.13M |
EyePoint Pharmaceuticals | 616.68M |
SI-BONE | 613.54M |
Varex Imaging | 611.86M |
Cabaletta Bio | 595.25M |
Harrow Health | 591.58M |
Aerovate Therapeutics | 591.43M |